NovaBay Pharmaceuticals, Inc. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed May 13, 2016
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Common Stock
2016-05-09$1.91/sh+261,780$500,000→ 453,718 total
Footnotes (1)
- [F1]Share acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate of 4,079,058 to 9 accredited investors. The company expects to sell another 2,094,241 pursuant to those same agreements on July 31, 2016.